Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB (change energy unit to kcal/mol)
Found 336 hits in this display
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
Ki: 0.420nMAssay Description:Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandMore data for this Ligand-Target Pair
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
Ki: 0.800nMAssay Description:Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2C receptor expressed in CHO cell membranes incubated for 60 minsMore data for this Ligand-Target Pair
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
Ki: 1.20nMAssay Description:Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2B receptor expressed in CHO cell membranes incubated for 60 minsMore data for this Ligand-Target Pair
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
Ki: 2nMAssay Description:Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligandMore data for this Ligand-Target Pair
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
Ki: 3.10nMAssay Description:Displacement of [3H]RX 821002 from human recombinant adrenergic alpha-2A receptor expressed in CHO cell membranes incubated for 60 minsMore data for this Ligand-Target Pair
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
Ki: 4.40nMAssay Description:Compound was evaluated for inhibition of binding of [3H]-yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-cloneMore data for this Ligand-Target Pair
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
Ki: 13nMAssay Description:Binding affinity to alpha-2 adrenergic receptor determined by measurement of [3H]yohimbine displacement from rat cortical membraneMore data for this Ligand-Target Pair
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
Ki: 45nMAssay Description:In vitro binding affinity was measured as the inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor of rat cortical membranesMore data for this Ligand-Target Pair
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
Ki: 84nMAssay Description:Binding affinity against alpha-2 adrenergic receptor was determined by the displacement of [3H]clonidine from rat brain cortical membranesMore data for this Ligand-Target Pair
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
Ki: 190nMAssay Description:Binding affinity against alpha-2 adrenergic receptor was determined by the displacement of [3H]prazosin from rat brain cortical membranesMore data for this Ligand-Target Pair
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
Ki: 360nMAssay Description:In vitro binding affinity was measured as the inhibition of [3H]WB-4101 binding to alpha-1 adrenergic receptor of rat cortical membranesMore data for this Ligand-Target Pair
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
Ki: 398nMAssay Description:Binding affinity to alpha-1 adrenergic receptor determined by measurement of [3H]prazosin displacement from rat cortical membraneMore data for this Ligand-Target Pair
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50203564((1R,2S,4aR,13bS,14aS)-2-hydroxy-1,2,3,4,4a,5,7,8,1...)
IC50: 3.67nMAssay Description:Displacement of [3H]MK9112 from human recombinant adrenergic alpha2A receptor expressed in insect Sf9 cells after 60 minsMore data for this Ligand-Target Pair
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
IC50: 8nMAssay Description:Inhibition of [3H]p-aminoclonidine (PAC) binding to alpha-2 adrenergic receptor of purified human platelet plasma membranesMore data for this Ligand-Target Pair
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
IC50: 9.10nMAssay Description:Alpha-2 adrenergic receptor activity was assessed from the ability to inhibit [3H]yohimbine binding to rat cerebral cortex preparationMore data for this Ligand-Target Pair
BDBM50203564((1R,2S,4aR,13bS,14aS)-2-hydroxy-1,2,3,4,4a,5,7,8,1...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
IC50: 170nMAssay Description:Compound was evaluated for the displacement of [3H]yohimbine in acetonitrile/acetic acid anti-corynanthine MIPs for Alpha-2 adrenergic receptorMore data for this Ligand-Target Pair
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
IC50: 1.00E+3nMAssay Description:Alpha-1-adrenolytic activity was assessed from the ability to inhibit [3H]prazosin binding to rat cerebral cortex preparationMore data for this Ligand-Target Pair
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
Kd: 1.50E+5nMAssay Description:Dissociation constant in low affinity sites where the binding is in 50 mM phosphate buffer for Alpha-2 adrenergic receptorMore data for this Ligand-Target Pair
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
Kd: 1.50E+5nMAssay Description:Dissociation constant in low affinity sites where the binding is in 50 mM phosphate buffer for Alpha-2 adrenergic receptorMore data for this Ligand-Target Pair
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
Kd: 2.30E+3nMAssay Description:Dissociation constant in high affinity sites where the binding is in 50 mM phosphate buffer for Alpha-2 adrenergic receptorMore data for this Ligand-Target Pair
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
Kd: 5.40E+6nMAssay Description:Dissociation constant in low affinity sites where the binding is in acetonitrile/acetic acid for Alpha-2 adrenergic receptorMore data for this Ligand-Target Pair
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
Kd: 4.70E+4nMAssay Description:Dissociation constant in high affinity sites where the binding is in acetonitrile/acetic acid for Alpha-2 adrenergic receptorMore data for this Ligand-Target Pair
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
Kd: 4.70E+4nMAssay Description:Dissociation constant in high affinity sites where the binding is in acetonitrile/acetic acid for Alpha-2 adrenergic receptorMore data for this Ligand-Target Pair
BDBM50203564((1R,2S,4aR,13bS,14aS)-2-hydroxy-1,2,3,4,4a,5,7,8,1...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
Kd: 2.30E+3nMAssay Description:Dissociation constant in high affinity sites where the binding is in 50 mM phosphate buffer for Alpha-2 adrenergic receptorMore data for this Ligand-Target Pair
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
BDBM50013515((+)-yohimbine | (16alpha,17alpha)-17-hydroxyyohimb...)
Kd: 5.40E+6nMAssay Description:Dissociation constant in low affinity sites where the binding is in acetonitrile/acetic acid for Alpha-2 adrenergic receptorMore data for this Ligand-Target Pair
Displayed 1 to 50 (of 336 total ) | Next | Last >>